Insights

Expansion Opportunities Shionogi Inc. is actively pursuing acquisitions and expanding its US footprint, signaling openness to partnerships, co-development deals, and potential regional distribution agreements to accelerate portfolio growth.

COVID-19 Antivirals With an investigational oral antiviral pipeline for COVID-19 and the U.S. launch of XOCOVA, there is a clear opportunity to position complementary antiviral therapies, diagnostic partnerships, and payer-ready deployment strategies.

Strategic Partnerships Strong collaboration history with industry, government, biotech, and academia suggests receptiveness to joint ventures, research collaborations, and funded clinical programs that could broaden access and accelerate product development.

Healthcare Market Fit A substantial U.S. payer and hospital network demand for innovative antimicrobials and antiviral treatments aligns with Shionogi’s legacy in antibiotics and recent COVID-19 prevention products, indicating opportunity for preferred supplier arrangements and value-based contracts.

Innovation Ecosystem Ongoing R&D in Fragile X, stroke, metabolic disorders, and oncology, along with active investment via corporate ventures, points to openings for co-development, licensing, and academic or biotech partnerships to enrich the portfolio.

Similar companies to Shionogi Inc. (U.S.)

Shionogi Inc. (U.S.) Tech Stack

Shionogi Inc. (U.S.) uses 8 technology products and services including Qlik, WordPress, SAP, and more. Explore Shionogi Inc. (U.S.)'s tech stack below.

Media & News

Shionogi Inc. (U.S.)'s Email Address Formats

Shionogi Inc. (U.S.) uses at least 4 email formats:
Shionogi Inc. (U.S.) Email FormatsExamplePercentage
First.Last@shionogi.comJohn.Doe@shionogi.com
69%
FLast@shionogi.comJDoe@shionogi.com
29%
FirstLast@shionogi.comJohnDoe@shionogi.com
1%
First.Middle@shionogi.comJohn.Michael@shionogi.com
1%

Frequently Asked Questions

What is Shionogi Inc. (U.S.)'s phone number?

Minus sign iconPlus sign icon
You can contact Shionogi Inc. (U.S.)'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Shionogi Inc. (U.S.)'s official website and social media links?

Minus sign iconPlus sign icon
Shionogi Inc. (U.S.)'s official website is shionogi.com and has social profiles on LinkedIn.

How much revenue does Shionogi Inc. (U.S.) generate?

Minus sign iconPlus sign icon
As of August 2026, Shionogi Inc. (U.S.)'s annual revenue is estimated to be $500M - $1B.

What is Shionogi Inc. (U.S.)'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Shionogi Inc. (U.S.)'s SIC code is 2834 - Pharmaceutical Preparations and NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Shionogi Inc. (U.S.) have currently?

Minus sign iconPlus sign icon
As of August 2026, Shionogi Inc. (U.S.) has approximately 696 employees across 5 continents, including North America, Europe and Asia. Key team members include Chief Executive Officer: S. G., Chief Executive Officer: S. P. and Chief Medical Officer: T. D. N. Explore Shionogi Inc. (U.S.)'s employee directory with LeadIQ.

What industry does Shionogi Inc. (U.S.) belong to?

Minus sign iconPlus sign icon
Shionogi Inc. (U.S.) operates in the Pharmaceutical Manufacturing industry.

What technology does Shionogi Inc. (U.S.) use?

Minus sign iconPlus sign icon
Shionogi Inc. (U.S.)'s tech stack includes Qlik, WordPress, SAP, Snowflake, Microsoft 365, Azure Active Directory, DocuSign and Webex.

What is Shionogi Inc. (U.S.)'s email format?

Minus sign iconPlus sign icon
Shionogi Inc. (U.S.)'s email format typically follows the pattern of First.Last@shionogi.com. Find more Shionogi Inc. (U.S.) email formats with LeadIQ.

When was Shionogi Inc. (U.S.) founded?

Minus sign iconPlus sign icon
Shionogi Inc. (U.S.) was founded in 2001.
Shionogi Inc. (U.S.) logo

Shionogi Inc. (U.S.)

Pharmaceutical ManufacturingNew Jersey, United States501-1000 Employees

Shionogi Inc. (U.S.) is a pharmaceutical manufacturing company located at 300 Campus Drive in Florham Park, New Jersey, employing 501-1000 people. Founded in 1878, the company focuses on developing treatments to improve patient lives and addresses global health challenges such as antimicrobial resistance and COVID-19. Historically, Shionogi introduced several novel antibiotics and medicines for HIV and influenza since the 1950s; currently, it is developing an investigational oral antiviral for COVID-19 and advancing clinical programs in Fragile X syndrome, acute ischemic stroke, metabolic disorders, and oncology. The organization combines in-house discovery with strategic partnerships and maintains collaborations with industry, government agencies, biotech companies, and academia to advance science and deliver innovations for patients in the United States and around the world. Recent information indicates ongoing external collaborations and corporate activity in 2026, reflecting continued engagement beyond its core research and development efforts.

Section iconCompany Overview

Phone number
SIC Code
2834 - Pharmaceutical Preparations
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2001
Employees
501-1000

Section iconFunding & Financials

  • $500M - $1B

    Shionogi Inc. (U.S.)'s revenue is estimated to be in the range of $500M - $1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.